Syverson Strege & CO Nevro Corp Transaction History
Syverson Strege & CO
- $394 Million
- Q3 2025
Shares
1 transactions
Others Institutions Holding NVRO
# of Institutions
14Shares Held
5.26MCall Options Held
0Put Options Held
150K-
Black Rock Inc. New York, NY3.6MShares$21 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA640KShares$3.74 Million2.48% of portfolio
-
Credit Suisse Ag Zurich, V8413KShares$2.41 Million0.01% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL370KShares$2.16 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY156KShares$913,4460.07% of portfolio
About NEVRO CORP
- Ticker NVRO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,387,800
- Market Cap $207M
- Description
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...